Original language | English (US) |
---|---|
Pages (from-to) | 1421-1423 |
Number of pages | 3 |
Journal | Journal of the American Academy of Dermatology |
Volume | 84 |
Issue number | 5 |
DOIs | |
State | Published - May 2021 |
Funding
Funding sources: Supported by a National Psoriasis Foundation Grant (to Drs Flood, Golbari, and Porter.)Disclosure: Dr Kimball is a consultant and investigator for AbbVie, Lilly, Janssen, Bristol Myers Squibb, UCB, Novartis, and Pfizer and has received fellowship funding from Janssen and AbbVie. Drs Kumar, Flood, Golbari, Charrow, and Porter have no conflicts of interest to declare. Funding sources: Supported by a National Psoriasis Foundation Grant (to Drs Flood, Golbari, and Porter.)
ASJC Scopus subject areas
- Dermatology